569 Targeting IL-15 delivery to PD-L1 expressing tumors with an Anti-PD-L1-IL-15 cytokine fusion IgM to enhance T Cell and NK Cell Mediated tumor cytotoxicity

Similar Items

• 711 IGM-7354 is an anti-PD-L1 IgM antibody and IL-15 cytokine fusion that enhances NK and CD8+ T cell proliferation and tumor cytotoxicity plus potently reverses T cell exhaustion
  by: Maya Kotturi, et al.
  Published: (2021-11-01)
• Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
  by: Karin M. Knudson, et al.
  Published: (2019-03-01)
• Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy
  by: Shaojie Hu, et al.
  Published: (2024-04-01)
• Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
  by: Jeffrey Schlom, et al.
  Published: (2020-05-01)
• GDF15 Contributes to the Regulation of the Mechanosensitive Responses of PdL Fibroblasts through the Modulation of IL-37
  by: Julia Steinmetz, et al.
  Published: (2024-02-01)